A 2012 Oxford University study, published in The Lancet medical journal, showed that even very low-risk patients benefited from taking cholesterol-lowering statins.
Rory Collins, professor of medicine at Oxford University, worked on the research and said the number of people who could begin taking statins as a result of the new Nice guidance "would be in the the order" of around five million.
He added: "The evidence is very strong that the treatment is cost-effective at these lower levels. Doctors are now in a position to offer statins on this basis."
He said it was up to individual patients to decide whether they wanted to take statins, based on their risk assessment, but Nice's strategy would "reduce the burden on the health service".
The NHS estimates that statins save 7,000 lives a year in the UK.
More top news
When Alison Powell's four-year-old Labrador Missy would not stop sniffing and pawing her, she knew it was more than simple canine affection.
Police have confirmed that six arrests were made as part of their operation for the Arsenal v Galatasaray Champions League match
A Banksy mural, possibly worth thousands of pounds, has been erased by a council in Essex after a complaint that it was "racist".